Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Aquaflora is a line of homeopathic remedies designed to address symptoms associated with *Candida albicans* overgrowth, commonly known as candidiasis. Developed by King Bio, these products utilize the homeopathic principle of isopathy, which involves using highly diluted preparations of the causative agent—in this case, *Candida albicans*—to stimulate the body's natural immune and self-healing responses. The formulations typically include a blend of homeopathic ingredients such as *Echinacea*, *Baptisia tinctoria*, and *Thuja occidentalis*, which are intended to support detoxification and alleviate systemic symptoms like digestive distress, fatigue, and yeast infections. As a homeopathic product, it is regulated as a drug under the Homeopathic Pharmacopoeia of the United States (HPUS).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Aquaflora.